Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential High-Dose Chemotherapy, Stem Cell Rescue, Interferon/Thalidomide, and Pamidronate in Multiple Myeloma
NCT00004088Phase 2Completed
- Sponsor
- City of Hope
- Start
- Jul 1999
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of melphalan, busulfan, cyclophosphamide, interferon alfa, pamidronate in multiple myeloma (MM), sponsored by City of Hope. Started Jul 1999; status: completed.
02
Drugs
melphalanbusulfancyclophosphamideinterferon alfapamidronate
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00004088.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004088.